In vivo regional cerebral blood volume: Quantitative assessment with 3D T1-weighted pre- and postcontrast MR imaging

Radiology

Volumn 201, Issue 1, 1996, Pages 106-112

  Kuppusamy, Karthikeyan ^a,b   Lin, Weili ^a   Cizek, Gregory R ^a   Haacke, E Mark ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

Blood, volume; Cerebral blood vessels, anatomy; Cerebral blood vessels, MR; Magnetic resonance (MR), maximal intensity projection; Magnetic resonance (MR), vascular studies; Magnetic resonance (MR), volume measurement

Indexed keywords

ADOLESCENT; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; CHILD; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE QUALITY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THREE DIMENSIONAL IMAGING;

EID: 0029833429     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.201.1.8816529     Document Type: Article

References (44)

1. Warach S, Li W, Ronthal M, Edelman RR. Acute cerebral ischemia: evaluation with dynamic contrast-enhanced MR imaging and MR angiography. Radiology 1992; 182:41-17.
2. KucharcZyk J, Roberts T, Moseley ME, Watson A. Contrast-enhanced perfusion sensitive MR imaging in diagnosis of cerebrovascular disorders. JMRI 1993; 3:241-245.
3. Hamberg LM, Macfarlane R, Tasdemiroglu E, et al. Measurement of cerebrovascular changes in cats after transient ischemia using dynamic magnetic resonance imaging. Stroke 1993; 24:444-450.
4. Duyn JH, Van Gelderen P, Barker P, Frank JA, Mattay VS, Moonen CTW. 3D bolus tracking with frequency shifted BURST MRI. J Comput Assist Tomogr 1994; 18:680-687.
5. Warach S, Levin JM, Schomer D, Holman BL, Edelman RR. Hyperperfusion of ictal seizure focus demonstrated by magnetic resonance perfusion imaging: SPECT, EEC and clinical correlation. AJNR 1994; 15:965-968.
6. Rosen BR, Belliveau JW, Aronen HJ, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991; 22:293-299.
7. Maeda M, Itoh S, Kimura H, et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. Radiology 1993; 189:233-238.
8. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191:41-51.
9. Maeda M, Itoh S, Kimura H, et al. Vascularity of meningiomas and neuromas: assessment with dynamic susceptibility-contrast MR imaging. AJR 1994; 181-186.
10. Guckel F, Brix G, Rempp K, Deimling M, Rother J, Georgi M. Assessment of cerebral blood volume with dynamic susceptibility contrast enhanced gradient-echo imaging. J Comput Assist Tomogr 1994; 18:344-351.
11. Belliveau JW, Kennedy D Jr, McKinstry RC, et al. Functional mapping of the human visual cortex by magnetic resonance imaging Science 1991; 254:716-719.
12. Zigun JR, Frank JA, Barrios FA, et al. Measurement of relative cerebral blood volume changes with visual stimulation by "double dose" gadopentetate-dimeglumine-enhanced dynamic magnetic resonance imaging. Invest Radiol 1993; 29:S157-S160.
13. Brasch RC, Bennett HF. Mechanisms of contrast enhancement for MRI. In: Bydder G, Felix R, Bucheler E, et al, eds. Contrast media in MRI. International workshop. Berlin, Germany: Medicom, 1990; 9-15.
14. Yuh WTC, Fischer DJ, Engleken JD, et al. MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. Radiology 1991; 180:485-491.
15. Hendrick RE, Haacke EM. Basic physics of MR contrast agents and maximization of image contrast. JMRI 1993; 3:137-148.
16. Li D, Haacke EM, Tarr RW, et al. Magnetic resonance imaging of the brain with Gd-DTPA: comparison of T1-weighted spin-echo and 3D gradient-echo sequences. JMRI 1996; 6:415-424.
17. Schorner W, Laniado M, Niendorf HP, Schubert C, Felix R. Time-independent changes in image contrast in brain tumors after gadolinium-DTPA. AJNR 1986; 7:1013-1020.
18. Bydder GM, Kingsley PE, Brown J, Niendorf HP, Young IR. MR imaging of meningiomas including studies with and without gadolinium-DTPA. J Comput Assist Tomogr 1985; 9:690-697.
19. Niendorf HP, Laniado M, Semmler W, Schorner W, Felix R. Dose administration of gadolinium-DTPA in MR imaging of intracranial tumors. AJNR 1987; 8:803-815.
20. Graif M, Bydder GM, Steiner RE, Niendorf HP, Thomas DGT, Young IR. Contrast enhanced MR imaging of malignant brain tumors. AJNR 1985; 6:855-862.
21. Villringer R, Rosen BR, Belliveau JB, et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988; 6:164-174.
22. McConnell J. The theory of nuclear magnetic resonance relaxation in liquids. Cambridge, England: Cambridge University Press, 1987.
23. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14:249-265.
24. Levin JM, Kaufman MJ, Ross MH, et al. Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state, and hemodynamic perturbation. Magn Reson Med 1995; 34:655-663.
25. Le Bihan D. Theoretical principle of perfusion imaging: application to magnetic resonance imaging. Invest Radiol 1992; 27:S6-511.
26. Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz, WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994; 193:637-641.
27. Bahn MM. A single step method for estimating local cerebral blood volume from susceptibility contrast MRI. Magn Reson Med 1995; 33:309-317.
28. Moseley ME, White DL, Wang SC, et al. Determination of cerebral blood volume using intravascular MR contrast agent (abstr). Presented at the 27th Annual Meeting of the American Society of Neuroradiology, Orlando, Fla, March 19-24, 1989.
29. White DL, Wang SC, Roth, et al. Determination of perfused cerebral blood volume using an intravascular MR contrast agent (abstr). In: Book of abstracts; Society of Magnetic Resonance in Medicine 1989. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1989; 806.
30. 1H MRI and intravascular contrast agent study. Magn Reson Med 1992; 23:21-30.
31. Schwarzbauer C, Syha J, Haase A. Quantification of regional blood volumes using rapid T1 mapping. Magn Reson Med 1993; 29:709-712.
32. Schwarzbauer C, Zange J, Noth U, Adolf H, Deichmann R, Haase A. Quantitative dynamical mapping of regional cerebral blood volumes (abstr). Proc Soc Magn Reson 1994; 1:197.
33. Syha J, Hillenbrand C, Haupt CI, Blasinger K, Haase A. Evaluation of rCBV changes in the rat brain by infusion of an intravascular contrast agent (abstr). Proc Soc Magn Reson 1994; 1:447.
34. Haase A, Stodal H, Morrissey SP, et al. In vivo measurements of contrast media kinetics with fast quantitative MR relaxation time imaging (abstr). Proc Soc Magn Reson 1995; 1:170.
35. Grubb RL, Phelps ME, Ter-Pogossian MM. Regional blood volume in humans: x-ray fluorescence studies. Arch Neurol 1973; 28:31-44.
36. Sakai F, Nakazawa K, Tazaki Y, et al. Regional cerebral blood volume and hematocrit measured in normal human volunteers by single photon emission computed tomography. J Cereb Blood Flow Metab 1985; 5:207-213.
37. Perlmutter JS, Powers WJ, Herscovitch P, Fox PT, Raichle ME. Regional assymetries of cerebral blood flow, blood volume, and oxygen utilization and extraction in normal volunteers. J Cereb Blood Flow Metab 1987; 7:64-67.
38. Brooks DJ, Beaney RP, Leenden KL, Marshall J, Thomas DJ, Jones T. Regional cerebral oxygen utilization, blood flow and blood volume in benign intracranial hypertension studied by PET. Neurology 1985; 35:1030-1034.
39. Leggett RW, Williams LR. Suggested reference values for regional blood volumes in humans. Health Phys 1991; 60:139-154.
40. Mugler JP, Brookeman JR. Theoretical analysis of gadopentate dimeglumine enhancement imaging of the brain: comparison of 2D spinecho and 3D gradient echo sequences. JMRI 1993; 3:761-769.
41. Hylton NM, Frankel SD, Esserman LJ, et al. High resolution 3D maps of contrast enhancement patterns in breast tumors (abstr). Proc Soc Magn Reson 1995; 1:439.
42. Bradley WG, Yuh WTC, Bydder GM. Use of MR imaging contrast agents in the brain. JMRI 1993; 3:199-218.
43. Bruening R, Kwong K, Vevea et al. Cerebral blood volume maps in primary brain tumors: implementation of T1-effects using echo-planar imaging (abstr). Proc Soc Magn Reson 1994; 1:196.
44. Hasso AN, Brown KD. Use of Gadolinium Chelates in MR imaging of lesions of the extracranial head and neck. JMRI 1993; 3:247-263.